Elevated interleukin-6 levels in the ovarian hyperstimulation syndrome: Ovarian immunohistochemical localization of interleukin-6 signal

Obstetrics and Gynecology

Volumn 87, Issue 4, 1996, Pages 581-587

  Loret De Mola, J Ricardo ^a,b   Flores, Juan Pablo ^a   Baumgardner, Gavin P ^a   Goldfarb, James M ^a   Gindlesperger, Victoria ^a   Friedlander, Miriam A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FERTILIZATION IN VITRO; HUMAN; IMMUNOHISTOCHEMISTRY; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 0029988804     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00456-4     Document Type: Article

References (22)

1. Loukides JA, Loy RA, Edwards R, Honig J, Visintin I, Polan ML. Human follicular fluid contain tissue macrophages. J Clin Endocrinol Metabol 1990;71:1363-7.
2. Adashi EY. The potential relevance of cytokines to ovarian physiology: The emergent role of resident ovarian cells of the white blood cell series. Endocrinol Rev 1990;11:454-64.
3. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993;269:1829-35.
4. Friedlander MA, Loret de Mola JR, Goldfarb JM. Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil Steril 1993;60:826-33.
5. Helle M, Boeije L, Aarden LA. Functional discrimination between IL-6 and IL-1. Eur J Immunol 1988;18:1535-40.
6. Bergh PA, Navot D. Ovarian hyperstimulation syndrome: A review of pathophysiology. J Assist Reprod Genet 1992;9:429-38.
7. Yarali H, Fleige-Zahradka BG, Yuen BH, McComb PF. The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary. Fertil Steril 1993;59:657-61.
8. Pride SM, Yuen BH, Moon YS, Leung PCS. Relationship of gonadotropin-releasing hormone, danazol, and prostaglandin blockade to ovarian enlargement and ascites formation of the ovarian hyperstimulation syndrome in the rabbit. Am J Obstet Gynecol 1986;154:1155-60.
9. Borenstein R, Elhalah U, Lunenfeld B, Shoham-Schwartz Z. Severe ovarian hyperstimulation syndrome: A reevaluated therapeutic approach. Fertil Steril 1989;51:791-5.
10. Balasch J, Arroyo V, Fabregues F, Salo J, Jimenez W, Pare JC, et al. Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome. Ann Intern Med 1994;121:27-33.
11. Gery I, Gershow RK, Waksman BH. Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med 1972;136:128-42.
12. Konickx PA, Ranaer M, Brosens IA. Origin of peritoneal fluid in women. An ovarian exudation product. Br J Obstet Gynaecol 1980;87:177-83.
13. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
14. Gershenwald JE, Fong YM, Fahey TJ III, Galvano SE, Chizzonite R, Kilian PL, et al. Interleukin-1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci U S A 1990;87:4966-70.
15. Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Monogue KB, Kenney JS, et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin-1β and interleukin-6 appearance during lethal bacteremia. J Exp Med 1989;170:1627-33.
16. Granowitz EV, Vannier E, Poutsiaka DD, Dinarello CA. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. Interleukin-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood 1992;79:2364-9.
17. Buyalos RP, Watson JM, Martinez-Maza O. Detection of interleukin-6 in human follicular fluid. Fertil Steril 1992;57:1230-4.
18. Motro B, Itin A, Sachs L, Keshet E. Pattern of interleukin-6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A 1990;87:3092-6.
19. Erroi A, Sironi M, Chiaffarino F, Zhen-Guo C, Mengozzi M, Mantovani A. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int J Cancer 1989;44:795-801.
20. McClure N, Healy DL, Rogers PA, Sullivan J, Beaton L, Haning RV, et al. Vascular endothelial growth factor as a capillary agent in OHSS. Lancet 1994;34:235-6.
21. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10.
22. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment. Fertil Steril 1992;58:249-61.